1-800-526-8630
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1 of 5
FEATURED COMPANIES
- ALLERGAN
- Integra LifeSciences
- Medtronic
- MiMedx Group
- Organogenesis
- Zimmer Biomet
- MORE
About Regenerative Medicine
Regenerative medicine augments, repairs, replaces or regenerates organs and tissue that have been damaged by disease, injury, or even by the natural aging process.
The analysts forecast the global regenerative medicine market to grow at a CAGR of 18.96% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global regenerative medicine market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Key vendors
READ MORE
Regenerative medicine augments, repairs, replaces or regenerates organs and tissue that have been damaged by disease, injury, or even by the natural aging process.
The analysts forecast the global regenerative medicine market to grow at a CAGR of 18.96% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global regenerative medicine market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Key vendors
- ALLERGAN
- Integra LifeSciences
- Medtronic
- MiMedx Group
- Organogenesis
- Zimmer Biomet
- Increasing prevalence of chronic diseases
- For a full, detailed list, view the full report
- Uncertain regulatory approval
- For a full, detailed list, view the full report
- Emerging technological advances
- For a full, detailed list, view the full report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
Note: Product cover images may vary from those shown
2 of 5
FEATURED COMPANIES
- ALLERGAN
- Integra LifeSciences
- Medtronic
- MiMedx Group
- Organogenesis
- Zimmer Biomet
- MORE
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 12: DRIVERS AND CHALLENGES
Exhibit 01: Global medical devices market: Market size 2017
Exhibit 02: Global medical devices market: Segmentation
Exhibit 03: Market characteristics
Exhibit 04: Global regenerative medicine market: Segmentation
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Global regenerative medicine market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global regenerative medicine market - Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global regenerative medicine market - Year over year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global regenerative medicine market by technology - Market share 2017-2022 (%)
Exhibit 19: Comparison by technology
Exhibit 20: Global regenerative medicine market by cell and tissue-based therapy - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global regenerative medicine market by cell and tissue-based therapy - Year over year growth 2018-2022 (%)
Exhibit 22: Approved gene therapy products
Exhibit 23: Global regenerative medicine market by gene therapy - Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Global regenerative medicine market by gene therapy - Year over year growth 2018-2022 (%)
Exhibit 25: Market opportunity by technology
Exhibit 26: Global regenerative medicine market: Segmentation by application 2017 (% share)
Exhibit 27: Customer landscape
Exhibit 28: Global regenerative medicine market by region - Market share 2017-2022 (%)
Exhibit 29: Global regenerative medicine market: Regional comparison
Exhibit 30: Regenerative medicine market in Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 31: Regenerative medicine market in Americas - Year over year growth 2018-2022 (%)
Exhibit 32: Top three countries in Americas
Exhibit 33: Regenerative medicine market in EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 34: Regenerative medicine market in EMEA - Year over year growth 2018-2022 (%)
Exhibit 35: Top three countries in EMEA
Exhibit 36: Regenerative medicine market in APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 37: Regenerative medicine market in APAC - Year over year growth 2018-2022 (%)
Exhibit 38: Top three countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: ALLERGAN - Overview
Exhibit 46: ALLERGAN - Business segments
Exhibit 47: ALLERGAN - Organizational developments
Exhibit 48: ALLERGAN - Geographic focus
Exhibit 49: ALLERGAN - Segment focus
Exhibit 50: ALLERGAN - Key offerings
Exhibit 51: ALLERGAN - Key customers
Exhibit 52: Integra LifeSciences - Overview
Exhibit 53: Integra LifeSciences - Business segments
Exhibit 54: Integra LifeSciences - Organizational developments
Exhibit 55: Integra LifeSciences - Geographic focus
Exhibit 56: Integra LifeSciences - Segment focus
Exhibit 57: Integra LifeSciences - Key offerings
Exhibit 58: Integra LifeSciences - Key customers
Exhibit 59: Medtronic - Overview
Exhibit 60: Medtronic - Business segments
Exhibit 61: Medtronic - Organizational developments
Exhibit 62: Medtronic - Geographic focus
Exhibit 63: Medtronic - Segment focus
Exhibit 64: Medtronic - Key offerings
Exhibit 65: Medtronic - Key customers
Exhibit 66: MiMedx Group - Overview
Exhibit 67: MiMedx Group - Business segments
Exhibit 68: MiMedx Group - Organizational developments
Exhibit 69: MiMedx Group - Geographic focus
Exhibit 70: MidMedx Group - Segment focus
Exhibit 71: MidMedx Group - Key offerings
Exhibit 72: MiMedx Group - Key customers
Exhibit 73: Organogenesis - Overview
Exhibit 74: Organogenesis - Business segments
Exhibit 75: Organogenesis - Organizational developments
Exhibit 76: Organogenesis - Geographic focus
Exhibit 77: Organogenesis - Segment focus
Exhibit 78: Organogenesis - Key offerings
Exhibit 79: Organogenesis - Key customers
Exhibit 80: Zimmer Biomet - Overview
Exhibit 81: Zimmer Biomet - Business segments
Exhibit 82: Zimmer Biomet - Organizational developments
Exhibit 83: Zimmer Biomet - Geographic focus
Exhibit 84: Zimmer Biomet - Segment focus
Exhibit 85: Zimmer Biomet - Key offerings
Exhibit 86: Zimmer Biomet - Key customers
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Segmentation by technology
- Comparison by technology
- Global regenerative medicine market by cell and tissue-based therapy
- Global regenerative medicine market by gene therapy
- Market opportunity by technology
- Segmentation by application
- Global regenerative medicine market by musculoskeletal application
- Global regenerative medicine market by dermatology application
- Global regenerative medicine market by cardiovascular application
- Global regenerative medicine market by other applications
- Geographical segmentation
- Regional comparison
- Regenerative medicine market in Americas - Market size and forecast 2017-2022
- Regenerative medicine market in EMEA - Market size and forecast 2017-2022
- Regenerative medicine market in APAC - Market size and forecast 2017-2022
- Market opportunity
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
- Increasing number of clinical trials
- Emerging technological advances
- Strategic partnerships and acquisitions
- Overview
- Landscape disruption
- Competitive landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- ALLERGAN
- Integra LifeSciences
- Medtronic
- MiMedx Group
- Organogenesis
- Zimmer Biomet
- List of abbreviations
Exhibit 01: Global medical devices market: Market size 2017
Exhibit 02: Global medical devices market: Segmentation
Exhibit 03: Market characteristics
Exhibit 04: Global regenerative medicine market: Segmentation
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Global regenerative medicine market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global regenerative medicine market - Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global regenerative medicine market - Year over year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global regenerative medicine market by technology - Market share 2017-2022 (%)
Exhibit 19: Comparison by technology
Exhibit 20: Global regenerative medicine market by cell and tissue-based therapy - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global regenerative medicine market by cell and tissue-based therapy - Year over year growth 2018-2022 (%)
Exhibit 22: Approved gene therapy products
Exhibit 23: Global regenerative medicine market by gene therapy - Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Global regenerative medicine market by gene therapy - Year over year growth 2018-2022 (%)
Exhibit 25: Market opportunity by technology
Exhibit 26: Global regenerative medicine market: Segmentation by application 2017 (% share)
Exhibit 27: Customer landscape
Exhibit 28: Global regenerative medicine market by region - Market share 2017-2022 (%)
Exhibit 29: Global regenerative medicine market: Regional comparison
Exhibit 30: Regenerative medicine market in Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 31: Regenerative medicine market in Americas - Year over year growth 2018-2022 (%)
Exhibit 32: Top three countries in Americas
Exhibit 33: Regenerative medicine market in EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 34: Regenerative medicine market in EMEA - Year over year growth 2018-2022 (%)
Exhibit 35: Top three countries in EMEA
Exhibit 36: Regenerative medicine market in APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 37: Regenerative medicine market in APAC - Year over year growth 2018-2022 (%)
Exhibit 38: Top three countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: ALLERGAN - Overview
Exhibit 46: ALLERGAN - Business segments
Exhibit 47: ALLERGAN - Organizational developments
Exhibit 48: ALLERGAN - Geographic focus
Exhibit 49: ALLERGAN - Segment focus
Exhibit 50: ALLERGAN - Key offerings
Exhibit 51: ALLERGAN - Key customers
Exhibit 52: Integra LifeSciences - Overview
Exhibit 53: Integra LifeSciences - Business segments
Exhibit 54: Integra LifeSciences - Organizational developments
Exhibit 55: Integra LifeSciences - Geographic focus
Exhibit 56: Integra LifeSciences - Segment focus
Exhibit 57: Integra LifeSciences - Key offerings
Exhibit 58: Integra LifeSciences - Key customers
Exhibit 59: Medtronic - Overview
Exhibit 60: Medtronic - Business segments
Exhibit 61: Medtronic - Organizational developments
Exhibit 62: Medtronic - Geographic focus
Exhibit 63: Medtronic - Segment focus
Exhibit 64: Medtronic - Key offerings
Exhibit 65: Medtronic - Key customers
Exhibit 66: MiMedx Group - Overview
Exhibit 67: MiMedx Group - Business segments
Exhibit 68: MiMedx Group - Organizational developments
Exhibit 69: MiMedx Group - Geographic focus
Exhibit 70: MidMedx Group - Segment focus
Exhibit 71: MidMedx Group - Key offerings
Exhibit 72: MiMedx Group - Key customers
Exhibit 73: Organogenesis - Overview
Exhibit 74: Organogenesis - Business segments
Exhibit 75: Organogenesis - Organizational developments
Exhibit 76: Organogenesis - Geographic focus
Exhibit 77: Organogenesis - Segment focus
Exhibit 78: Organogenesis - Key offerings
Exhibit 79: Organogenesis - Key customers
Exhibit 80: Zimmer Biomet - Overview
Exhibit 81: Zimmer Biomet - Business segments
Exhibit 82: Zimmer Biomet - Organizational developments
Exhibit 83: Zimmer Biomet - Geographic focus
Exhibit 84: Zimmer Biomet - Segment focus
Exhibit 85: Zimmer Biomet - Key offerings
Exhibit 86: Zimmer Biomet - Key customers
Note: Product cover images may vary from those shown
3 of 5
LOADING...
4 of 5
FEATURED COMPANIES
- ALLERGAN
- Integra LifeSciences
- Medtronic
- MiMedx Group
- Organogenesis
- Zimmer Biomet
- MORE
New Report Released: - Global Regenerative Medicine Market 2018-2022.
The author of the report recognizes the following companies as the key players in the global regenerative medicine market: ALLERGAN, Integra LifeSciences, Medtronic, MiMedx Group, Organogenesis, and Zimmer Biomet.
Commenting on the report, an analyst from the research team said: “One trend in the market is emerging technological advances. With the growing demand, vendors in the stem cell therapy market focus on investing in technological advancements such as using regenerated tracheas for transplant and 3D bioprinting to survive in this competitive market.”
According to the report, one driver in the market is increasing prevalence of chronic diseases. According to the Centers for Disease Control and Prevention (CDC), over 117 million individuals in the US had one of more chronic health conditions in 2012. Moreover, there is also an increase in the prevalence of acute wounds such as surgical and traumatic wounds across the globe and it has been observed that the global prevalence of surgical wounds was about 135,000 in 2016.
Further, the report states that one challenge in the market is uncertain regulatory approval. Cell therapy, gene therapy, and tissue engineering have been under development for several decades. However, their successful clinical application is still considered to be a recent phenomenon in both developed and developing countries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The author of the report recognizes the following companies as the key players in the global regenerative medicine market: ALLERGAN, Integra LifeSciences, Medtronic, MiMedx Group, Organogenesis, and Zimmer Biomet.
Commenting on the report, an analyst from the research team said: “One trend in the market is emerging technological advances. With the growing demand, vendors in the stem cell therapy market focus on investing in technological advancements such as using regenerated tracheas for transplant and 3D bioprinting to survive in this competitive market.”
According to the report, one driver in the market is increasing prevalence of chronic diseases. According to the Centers for Disease Control and Prevention (CDC), over 117 million individuals in the US had one of more chronic health conditions in 2012. Moreover, there is also an increase in the prevalence of acute wounds such as surgical and traumatic wounds across the globe and it has been observed that the global prevalence of surgical wounds was about 135,000 in 2016.
Further, the report states that one challenge in the market is uncertain regulatory approval. Cell therapy, gene therapy, and tissue engineering have been under development for several decades. However, their successful clinical application is still considered to be a recent phenomenon in both developed and developing countries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- ALLERGAN
- Integra LifeSciences
- Medtronic
- MiMedx Group
- Organogenesis
- Zimmer Biomet
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
